Glenmont, NY, United States of America

Bart E Burgess

This inventor holds 18 USPTO granted patents and 5 published patent applications, plus 1 CIPO patent and 6 EPO patents, primarily in Injection Devices. Top assignees: Regeneron Pharmaceuticals, Inc., Sanofi-A Ventis Deutschland Gmbh, Regeneran Pharmaceuticals, Inc.. Active years: 2019-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Bart E Burgess. Retrieved from https://idiyas.com/inventor/bart-e-burgess

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 18 

% Patents Active = 94.4

 

 

Average Co-Inventor Count = 5.2

ph-index = 8

Forward Citations = 257(Granted Patents)


Location History:

  • East Greenbush, NY (US) (2020 - 2021)
  • Glenmont, NY (US) (2019 - 2022)
  • Bernville, PA (US) (2022)
  • Virginville, PA (US) (2023)

Company Filing History:


Years Active: 2019-2026

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Auto-Injector
Aseptic Piercing
Injection Device
Anti-Roll Features
Injection Cap
Medical Devices
Drug Delivery
Needle Technology
Safety Mechanisms
Self-Administration
Device Design
18 patents (USPTO):Explore Patents

Title: Innovations by Bart E. Burgess: Pioneering Auto-Injector Technologies

Introduction: Bart E. Burgess, hailing from Bernville, Pennsylvania, is an innovative inventor known for his contributions to the field of medical devices. With a focus on auto-injector technology, Burgess has been instrumental in developing devices that enhance the administration of medications, improving efficiency and patient experience. He holds two patents that showcase his expertise and commitment to innovation in healthcare solutions.

Latest Patents: Burgess's most recent patents center around advanced auto-injector mechanisms. The first patent details an injection device featuring a carrier, needle, driver, shuttle, and a unique stop mechanism designed to maintain the driver in a deployed state. This innovative approach allows users to easily transition between the retracted and deployed configurations, ensuring precise medication delivery. The second patent revolves around an auto-injector that incorporates a container for medicament, a shuttle on a horizontal path, and an energy source utilizing pressurized fluid. This design includes an impediment that ensures the shuttle remains stationary until activation, enhancing safety and user control before administering the medication.

Career Highlights: Bart E. Burgess currently works at Regeneron Pharmaceuticals, Inc., a prominent biopharmaceutical company dedicated to developing and manufacturing life-transforming medicines. His role at Regeneron allows him to collaborate with a team of skilled professionals in advancing healthcare technologies. His patents reflect his deep understanding of both engineering and medical needs, demonstrating his ability to bridge the gap between innovation and practical application.

Collaborations: In his professional journey, Burgess has had the opportunity to collaborate with talented individuals such as Trevor Langley. Together, they contribute to the development of cutting-edge medical technologies that positively impact patient care. Their collaborations highlight the importance of teamwork in driving innovation within the industry.

Conclusion: Bart E. Burgess stands out as an influential inventor in the medical devices sector, specifically through his work on auto-injector technologies. With two significant patents to his name and a partnership with Regeneron Pharmaceuticals, Burgess's contributions are paving the way for improved medical treatments. His dedication to innovation underlines the critical role inventors play in advancing healthcare solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…